TickerFiles

BIOLARGO, INC. 10-K filing

Filed 2026-03-04 · Report date 2025-12-31 · 2025 FY

View Original SEC Filing

Filing metadata

Accession number
0001437749-26-006926
Form type
10-K
CIK
0000880242
Primary document
https://www.sec.gov/Archives/edgar/data/880242/000143774926006926/blgo20251231_10k.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BIOLARGO, INC..

Reported financial metrics

MetricCurrentPriorChange
Cost Of Revenue$4.4M--
Gross Profit$3.4M--
Operating Income$-14.9M--
Eps Basic-0.04--
Cash And Equivalents$3.9M--
Total Assets$8.3M--
Total Liabilities$6.8M--
Shareholders Equity$4.0M--
Operating Cash Flow$-8.3M--